Anti-PD-1 Therapy with Adjuvant Ablative Fractional Laser Improves Anti-Tumor Response in Basal Cell Carcinomas

SIMPLE SUMMARY: In some mouse models, ablative fractional laser (AFL) enhances the efficacy of anti-programmed cell death1 therapy (aPD-1), which was recently approved for basal cell carcinoma (BCC). In this explorative study, we aimed to assess locally applied AFL as an adjuvant to systemic aPD-1 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesen, Uffe Høgh, Wiinberg, Martin, Lerche, Catharina Margrethe, Jæhger, Ditte Elisabeth, Andresen, Thomas Lars, Haedersdal, Merete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699063/
https://www.ncbi.nlm.nih.gov/pubmed/34944945
http://dx.doi.org/10.3390/cancers13246326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699063/
https://www.ncbi.nlm.nih.gov/pubmed/34944945
http://dx.doi.org/10.3390/cancers13246326

Ejemplares similares